Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 510

1.

Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation.

Carretta MD, Alarcón P, Jara E, Solis L, Hancke JL, Concha II, Hidalgo MA, Burgos RA.

Eur J Pharmacol. 2009 Jan 14;602(2-3):413-21. doi: 10.1016/j.ejphar.2008.11.011. Epub 2008 Nov 13.

PMID:
19038244
2.

Andrographolide inhibits IFN-gamma and IL-2 cytokine production and protects against cell apoptosis.

Burgos RA, Seguel K, Perez M, Meneses A, Ortega M, Guarda MI, Loaiza A, Hancke JL.

Planta Med. 2005 May;71(5):429-34.

PMID:
15931581
3.
4.

Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.

Cianferoni A, Massaad M, Feske S, de la Fuente MA, Gallego L, Ramesh N, Geha RS.

J Allergy Clin Immunol. 2005 Dec;116(6):1364-71.

PMID:
16337472
5.
6.

Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.

Conrad DM, Furlong SJ, Doucette CD, Boudreau RT, Hoskin DW.

Cell Signal. 2009 Aug;21(8):1298-307. doi: 10.1016/j.cellsig.2009.03.014. Epub 2009 Mar 24.

PMID:
19324083
7.

Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.

Martínez-Martínez S, Gómez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, Redondo JM.

Mol Cell Biol. 1997 Nov;17(11):6437-47.

9.

c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.

Ortega-Pérez I, Cano E, Were F, Villar M, Vázquez J, Redondo JM.

J Biol Chem. 2005 May 27;280(21):20867-78. Epub 2005 Mar 2.

10.

Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.

Khalaf H, Jass J, Olsson PE.

BMC Immunol. 2010 May 27;11:26. doi: 10.1186/1471-2172-11-26.

11.

Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.

Manicassamy S, Sadim M, Ye RD, Sun Z.

J Mol Biol. 2006 Jan 20;355(3):347-59. Epub 2005 Nov 8.

PMID:
16309697
12.

Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation.

Zeyda M, Szekeres AB, Säemann MD, Geyeregger R, Stockinger H, Zlabinger GJ, Waldhäusl W, Stulnig TM.

J Immunol. 2003 Jun 15;170(12):6033-9.

13.
14.

Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.

Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S.

EMBO Rep. 2000 Nov;1(5):428-34.

15.

Acetate inhibits NFAT activation in T cells via importin beta1 interference.

Ishiguro K, Ando T, Maeda O, Ohmiya N, Niwa Y, Goto H.

Eur J Immunol. 2007 Aug;37(8):2309-16.

16.
17.

Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells.

Jhun BS, Lee JY, Oh YT, Lee JH, Choe W, Baik HH, Kim SS, Yoon KS, Ha J, Kang I.

Biochem Biophys Res Commun. 2006 Dec 29;351(4):986-92. Epub 2006 Nov 2.

PMID:
17097050
18.

(5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.

Zhou R, Wang JX, Tang W, He PL, Yang YF, Li YC, Li XY, Zuo JP.

Acta Pharmacol Sin. 2006 Dec;27(12):1616-21.

19.

Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.

Márquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Muñoz E.

J Pharmacol Exp Ther. 2004 Mar;308(3):993-1001. Epub 2003 Nov 14.

20.

UR-1505, a new salicylate, blocks T cell activation through nuclear factor of activated T cells.

Román J, de Arriba AF, Barrón S, Michelena P, Giral M, Merlos M, Bailón E, Comalada M, Gálvez J, Zarzuelo A, Ramis I.

Mol Pharmacol. 2007 Aug;72(2):269-79. Epub 2007 May 2.

Supplemental Content

Support Center